Noninvasive MRI Native T

Algorithms Animals Azepines / therapeutic use Benzamides / therapeutic use Child Female Humans Machine Learning Male Mice Mice, Transgenic Morpholines / therapeutic use Multiparametric Magnetic Resonance Imaging / methods N-Myc Proto-Oncogene Protein / antagonists & inhibitors Neuroblastoma / diagnostic imaging Precision Medicine / methods Protein Kinase Inhibitors / therapeutic use Pyrimidines / therapeutic use TOR Serine-Threonine Kinases / antagonists & inhibitors Time Factors Treatment Outcome

Journal

Cancer research

ISSN: 1538-7445

Titre abrégé: Cancer Res

Pays: United States

ID NLM: 2984705R

Informations de publication

Date de publication:
15 08 2020

Historique:

received: 14 01 2020

revised: 02 05 2020

accepted: 11 06 2020

pubmed: 1 7 2020

medline: 29 12 2020

entrez: 30 6 2020

Statut: ppublish

Résumé

Noninvasive early indicators of treatment response are crucial to the successful delivery of precision medicine in children with cancer. Neuroblastoma is a common solid tumor of young children that arises from anomalies in neural crest development. Therapeutic approaches aiming to destabilize

Identifiants

DOI: 10.1158/0008-5472.CAN-20-0133 PMID: 32595135

pubmed: 32595135

pii: 0008-5472.CAN-20-0133

doi: 10.1158/0008-5472.CAN-20-0133

doi:

Substances chimiques

Azepines 0

Benzamides 0

MLN 8237 0

Morpholines 0

N-Myc Proto-Oncogene Protein 0

Protein Kinase Inhibitors 0

Pyrimidines 0

vistusertib 0BSC3P4H5X

MTOR protein, human EC 2.7.1.1

TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng